1. | harleywoman509 | |
2. | aleciaax | |
3. | torojr |
1. | harleywoman509 | |
2. | aleciaax | |
3. | torojr |
1. | torojr 06/05/2018 Protalix BioTherapeutics Announces Additional Positive Results from Final Analysis of the Phase II Clinical Trial of OPRX-106 for the Treatment of Ulcerative Colitis |
2. | harleywoman509 01/12/2018 Found the industry news. |
3. | aleciaax 01/31/2018 Protalix BioTherapeutics' pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration |